Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
There is a new study that suggests there may be an easy way to diagnose Parkinson’s Disease from other similar diseases early on. This method relies on measuring…
A new drug called Austedo, has been approved by the FDA for the treatment of involuntary movements associated with chorea. Austedo is a small molecule drug designed to…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
A man signed up for treatment of his Parkinson’s Disease, but the therapy wasn’t medicine, it was cycling. In fact, researchers at the Cleveland Clinic have found that…
Dr. Robert Chen of the Institute of Medical Science at the University of Toronto, discusses the need for the study of brain plasticity in patients with movement disorders.…
An overflow of movement called Dyskinesia can impair someone’s quality of life. The movements can be fluid and dance like, jerking or slow, and extended muscle spasms. These…
Biomedical engineer Ayse Gunduz, of the University of Florida, explain the recent developments and intricacies of deep brain stimulation. The research being developed will show health professionals just…
